Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Clinical Colorectal Cancer
|
June 5, 2012
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment
Enzo Mammano, Francesca Galdi, Mariaelena Pierobon, et al.
International Journal of Molecular Sciences
|
September 9, 2016
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
Eva Dreussi, Erika Cecchin, Jerry Polesel, et al.
Cancers
|
June 27, 2019
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer
Debora Basile, Lorenzo Gerratana, Angela Buonadonna, et al.
Frontiers in Pharmacology
|
January 10, 2022
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
Elena De Mattia, Vincenzo Canzonieri, Jerry Polesel, et al.
Journal of Proteome Research
|
February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy
Julia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
Human Immunology
|
February 8, 2026
HLA-G alleles in Italian patients with locally advanced rectal cancer (LARC)
Lucia Scarabel, Erick C Castelli, Michela Zorzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2005
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy
Emanuel F Petricoin, Verena E Bichsel, Valerie S Calvert, et al.
Cancers
|
October 28, 2023
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas
Angela Buonadonna, Simona Scalone, Davide Lombardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 11, 2020
Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy
Erika Cecchin, Elena De Mattia, Eva Dreussi, et al.
BMC Cancer
|
April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks
Heiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Clinical Colorectal Cancer
|
June 5, 2012
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment
Enzo Mammano, Francesca Galdi, Mariaelena Pierobon, et al.
International Journal of Molecular Sciences
|
September 9, 2016
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
Eva Dreussi, Erika Cecchin, Jerry Polesel, et al.
Cancers
|
June 27, 2019
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer
Debora Basile, Lorenzo Gerratana, Angela Buonadonna, et al.
Frontiers in Pharmacology
|
January 10, 2022
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
Elena De Mattia, Vincenzo Canzonieri, Jerry Polesel, et al.
Journal of Proteome Research
|
February 9, 2008
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy
Julia D Wulfkuhle, Runa Speer, Mariaelena Pierobon, et al.
Human Immunology
|
February 8, 2026
HLA-G alleles in Italian patients with locally advanced rectal cancer (LARC)
Lucia Scarabel, Erick C Castelli, Michela Zorzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2005
Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy
Emanuel F Petricoin, Verena E Bichsel, Valerie S Calvert, et al.
Cancers
|
October 28, 2023
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas
Angela Buonadonna, Simona Scalone, Davide Lombardi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 11, 2020
Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy
Erika Cecchin, Elena De Mattia, Eva Dreussi, et al.
BMC Cancer
|
April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks
Heiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
Page
of 7